The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of the mTOR inhibitor sirolimus and the HDAC inhibitor vorinostat in patients with advanced malignancies.
 
Haeseong Park
No Relationships to Disclose
 
Ignacio Garrido-Laguna
No Relationships to Disclose
 
Aung Naing
No Relationships to Disclose
 
Siqing Fu
No Relationships to Disclose
 
Gerald Steven Falchook
Employment - HealthONE; Sarah Cannon Research Institute
Research Funding - ARMO BioSciences; AstraZeneca; Celgene; EMD Serono; Genmab; GlaxoSmithKline; Incyte; Kolltan Pharmaceuticals; MedImmune; Millennium; Novartis; Vegenics
Patents, Royalties, Other Intellectual Property - Handbook of Targeted Cancer Therapy
Travel, Accommodations, Expenses - EMD Serono; Millennium; Sarah Cannon Research Institute
 
Sarina Anne Piha-Paul
Research Funding - Biomarin; GlaxoSmithKline; Helix BioPharma; Merck; Novartis; Puma Biotechnology
 
Jennifer J. Wheler
No Relationships to Disclose
 
David S. Hong
Consulting or Advisory Role - Amgen; Eisai; H-S Medical; Janssen; Merck
 
Vivek Subbiah
No Relationships to Disclose
 
Apostolia Maria Tsimberidou
Research Funding - Baxter (Inst); Celgene (Inst); EMD Serono (Inst); Foundation Medicine (Inst); NCCN (Inst)
 
Ahmed Omar Kaseb
Honoraria - Bayer/Onyx
Consulting or Advisory Role - Bayer/Onyx
Research Funding - Bayer/Onyx
 
Yasuhiro Oki
Research Funding - Cell Medica; Curis; Infinity Pharmaceuticals; Janssen; Millennium; Novartis; Seagen; Spectrum Pharmaceuticals
Travel, Accommodations, Expenses - Dava Oncology
 
Ralph Zinner
No Relationships to Disclose
 
Shreyaskumar Patel
Consulting or Advisory Role - CytRx Corporation; Janssen; Novartis
Research Funding - Eisai; Janssen; Morphotek
 
Vivianne Marie Velez Bravo
No Relationships to Disclose
 
Michelle A. Fanale
Honoraria - Plexus; Research to Practice; Seagen; Takeda
Consulting or Advisory Role - Acetylon Pharmaceuticals; Amgen; Clarient; Spectrum Pharmaceuticals
Research Funding - Bristol-Myers Squibb; Celgene; Genentech; Gilead Sciences; MedImmune; Millennium; Molecular Templates; Novartis; Seagen
Travel, Accommodations, Expenses - Plexus; Research to Practice; Spectrum Pharmaceuticals; Takeda
 
Funda Meric-Bernstam
No Relationships to Disclose
 
Razelle Kurzrock
Stock and Other Ownership Interests - RScueRx
Honoraria - AACR; ASCO; Cancer Treament Centers of America; Cedars-Sinai; Clearview Healthcare Partners; CTRC-EAB San Antonio; Frankel Group; Janssen; Jubilant Biosys; Lynx Group; Merck; NCCN; SAIC NCI CCCT Investigational Drug Steering Committee; Segal Cancer Center; The Dedham Group; University of Arizona; Usha Mahajani Foundation
Consulting or Advisory Role - AACR; CTRC-EAB San Antonio; Janssen; Jubilant Biosys; Merck; SAIC NCI CCCT IDSE
Research Funding - Centocor Ortho Biotech; EMD Serono; EMD Serono; EMD Serono; Exelixis; GlaxoSmithKline; GlaxoSmithKline; Merck; Merck; Novartis; Roche/Genentech; XBiotech
Patents, Royalties, Other Intellectual Property - Patent; Patent; Patent; Patent
Travel, Accommodations, Expenses - Cancer Treament Centers of America; EMD Serono; Gateway Research Advisory Committee; Gateway Research Advisory Committee; Global Biomarkers Consortium; ICRP; WIN Pharma; WIN Pharma
 
Filip Janku
No Relationships to Disclose